PolyU showcases innovative research in AI and medicine-engineering integration at BIO International Convention 2025
PolyU participated in the BIO International Convention 2025 (BIO 2025) held in Boston from 16 to 19 June 2025. Showcasing its ground-breaking innovations and translational research across the fields of artificial intelligence (AI), medicine and engineering for global industry leaders, the University highlighted its interdisciplinary excellence and leading position in medical and health research.
The world’s largest biotechnology convention, BIO 2025 brought together over 20,000 industry leaders and professionals from about 70 countries and regions. It embraced all key aspects of the biotechnology ecosystem, spanning from research and development, clinical trials and manufacturing, to investment, business development and commercialisation.
Ten cutting-edge PolyU innovations in drug discovery, medical devices and diagnostics, biomedical engineering, rehabilitation technologies, optometry and food science were showcased at the Convention. Apart from presentations, the research teams also engaged in business forums and thematic discussions during the event to cultivate meaningful connections, forge strategic partnerships and explore new avenues for collaboration with global industry leaders.
RISA scholars-led innovations exhibited at BIO 2025 include:
“Hybrid Robotic IoT for Telerehabilitation after Stroke”, led by Prof. HU Xiaoling, Member of Research Institute for Smart Ageing (RISA) and RISports, and Associate Professor of the Department of Biomedical Engineering
“Novel Nutraceuticals for Neurodegenerative Diseases”, led by Prof. Simon LEE Ming-yuen, Management Committee Member of RCMI, Member of Research Institute for Future Food (RiFood) and RISA, and Chair Professor of Biomedical Sciences of the Department of Food Science and Nutrition
Building on its robust foundation in medical and health research, PolyU is dedicated to advancing interdisciplinary research at the convergence of medicine, AI, engineering, and data science, pioneering a new era of healthcare innovation, while also contributing to Hong Kong’s development into an international health and medical innovation hub.
Press release- https://polyu.me/4nb0HFA
Online coverage:
Mirage News- https://polyu.me/4kYPUg7
理大科研團隊參與於2025年6月16至19日在美國波士頓舉行的「國際生物科技大會2025」(BIO 2025),向來自世界各地的業界領袖展示大學的突破性研究及成果轉化,包括多項橫跨人工智能、醫學及工程領域的創新發明,彰顯理大於醫療及健康領域跨學科研究方面的雄厚實力及領導地位。
BIO 2025是全球最具規模及影響力的生物科技大會,匯聚來自近70 個國家或地區逾 20,000 名業界領袖和專業人士。大會內容涵蓋多個範疇,從科研開發、臨床試驗、製造,到投資、業務拓展及市場營銷等,全面覆蓋整個生物科技生態圈。理大於大會展示的十項跨學科研究成果,涵蓋藥物研發、醫療儀器與診斷、生物醫學工程、復康科技、視光學及食品科學等多個領域。此外,理大代表亦參與了大會舉辦的多場商業論壇及專題研討,與全球生物科技業界領袖進行深度交流,積極拓展國際協作網絡,開拓多元嶄新機遇。
於BIO 2025 展出由智齡研究院學者領導的創新成果包括:
由智齡研究院及體育科技研究院成員、生物醫學工程學系副教授胡曉翎教授領導的「多模態足踝機械人助中風患者遙距復康」
由中醫藥創新研究中心管理委員會成員、未來食品研究院及智齡研究院成員、食品科學與營養學系講座教授李銘源教授領導的「治療神經退化性疾病的新型營養保健品」
理大在醫療及健康領域擁有堅實的科研實力和基礎,一直致力推動結合醫學與人工智能、工程學及數據科學的跨學科研究項目,引領新世代醫療科技發展,助力香港建設成為國際醫療創新樞紐。
新聞稿 - https://polyu.me/4lgaeJH
網上報導:
Mirage News - https://polyu.me/4kYPUg7